SLXN Stock Analysis: Buy, Sell, or Hold?
SLXN - Silexion Therapeutics Corp Ordinary Shares
$1.88
0.00 (-0.02%)
▼
5d:
-25.71%
30d:
-28.94%
90d:
+214.16%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When SLXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SLXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SLXN is currently trading at $1.88, which is considered oversold relative to its 30-day fair value range of $2.37 to $2.77.
Technical Outlook: Technically, SLXN is in a uptrend. Immediate support is located at $1.50, while resistance sits at $2.63.
Market Sentiment: SLXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $60.00 (+3091.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLXN is in a uptrend. Immediate support is located at $1.50, while resistance sits at $2.63.
Market Sentiment: SLXN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $60.00 (+3091.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.37 -
$2.77
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3091.5% below Wall St target ($60.00)
- CAUTION: 5-day price weakness (-25.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.37 -
$2.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$2.63
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.10
Wall Street Target
$60.00
(+3091.5%)
Share & Embed Analysis
Last updated: August 03, 2026 3:29 PM ET
Data refreshes hourly during market hours. Next update: 4:29 PM
Data refreshes hourly during market hours. Next update: 4:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
